https://www.selleckchem.com/products/atn-161.html
9%, 85.4%, and 57.5%, respectively; = .014). Among B12-deficient hypothyroid patients, 7.5% had positive IFAB and 13.3% had positive tTG antibodies. We did not find a significant association of TPO positivity and B12 deficiency (OR, 0.69; 95% CI 0.3-1.57; = .147). We did not find a higher prevalence of B12 deficiency among hypothyroid patients nor an association with TPO positivity. Borderline B12 levels were more prevalent among hypothyroid patients. We did not find a higher prevalence of B12 deficiency among hypothyroid patients nor